Creative Diagnostics Launches SARS-CoV-2 Immunoassay Kits for Researchers

As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches SARS-CoV-2 immunoassay kits for direct detection of the new coronavirus and antibodies against SARS-CoV-2. New immunoassay kits including SARS-CoV-2 IgG ELISA Kit, SARS-CoV-2 IgM ELISA Kit, SARS-CoV-2 Antigen ELISA Kit, and SARS-COV-2 Total Antibody ELISA Kit are available at Creative Diagnostics.

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) at the end of 2019 has become a global pandemic and an unprecedented public health issue. Creative Diagnostics started developing a new test shortly after the outbreak has become known. Only a few weeks later, two ELISAs for the detection of Anti-SARS-CoV-2 antibodies of classes IgM and IgG and one ELISA for the detection of SARS-CoV-2 NP antigen were available. Both test systems are currently only available to research institutions as research-use-only products. Preparations for CE registration of these tests are underway.

For example, the SARS-CoV-2 Antigen ELISA Kit is based on the principle of a double antibody sandwich enzyme-linked immunoassay. This kit is intended for the quantitative detection of the recombinant SARS-COV-2 nucleoprotein antigen in human serum. It can recognize recombinant SARS-CoV Nucleoprotein / NP Protein, but not react with recombinant MERS-CoV Nucleoprotein / NP protein. The use of this kit for natural samples need be validated by the end user due to the complexity of natural targets and unpredictable interference. It is worth noting that it is for research use only, not for use in diagnostic procedures.

“Creative Diagnostics is glad to have such opportunity to collaborate with global scientists and promote the advancement of SARS-CoV-2 related research through open communication and the exchange of ideas among researchers. We will continue to expand our product portfolio to offer more quality immunoassay kits for scientists and participate in the global research of SARS-CoV-2 solutions. Creative Diagnostics experts are also accessible to support the research.” said Prof. Mike Knuth, M.D., the chief scientific officer of R&D department of Creative Diagnostics.

“Creative Diagnostics has a long-standing reputation amongst life science/bio-pharmaceutical industry for diagnostic kit development. To provide an opportunity to address existing issues, we’ll strengthen our capabilities in developing quality diagnostic kits especially immunoassay kits for the research community, and we’ll also focus on the custom solutions that support research needs to fight against the SARS-CoV-2.” said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics.

If you want to know more information about SARS-CoV-2 immunoassay kits or other coronavirus research materials, please contact Creative Diagnostics at 1-631-619-7922 or email to contact ( @ ) creative-diagnostics dot com dot

About Creative Diagnostics
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers’ assay development and manufacturing needs.

Leave a Reply

Your email address will not be published. Required fields are marked *